Dimethyl Fumarate API

Name	Dimethyl fumarate
Chinese name	富马酸二甲酯
Cas Number	624-49-7
Source	India
Qualifications	USDMF/-/-/-/-

Dimethyl fumarate enteric-coated capsules were approved by the FDA in March 2013 for sale in the United States, and have been approved for sale in the European Union, Canada and other places for the treatment of multiple sclerosis (MS). Dimethyl fumarate is the third multiple sclerosis drug that can be taken orally after fingolimod and teriflunomide. It has a better curative effect for multiple sclerosis recurrence, and has a low safety risk and resistance Good acceptability and other advantages. Compared with glatiramer acetate, dimethyl fumarate significantly reduces the results of major inflammatory diseases, and the recurrence rate of related autoimmune diseases is significantly reduced. In the first year of listing, sales reached 876 million U.S. dollars, and the following year’s sales were close to 3 billion U.S. dollars, with rapid growth and promising prospects.

Hot Tags: dimethyl fumarate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Fondaparinux API, Clofarabine API, Bemeprost API, Perindopril Tert butylamine Salt API, Escitalopram Oxalate API, Celecoxib API

• Previous: Linagliptin API
• Next: Vardenafil API